MedPath

Genes, Omega-3 Fatty Acids and Cardiovascular Disease Risk Factors

Not Applicable
Active, not recruiting
Conditions
Cardiovascular Disease
Interventions
Dietary Supplement: n-3 PUFA supplementation
Registration Number
NCT01343342
Lead Sponsor
Laval University
Brief Summary

The main purpose of this study is to examine whether n-3 PUFA-induced changes in metabolic risk factors are influenced by genetic variations within genes acting as fatty acids sensors.

Detailed Description

The main purpose of this study is to examine whether n-3 PUFA-induced changes in metabolic risk factors are influenced by genetic variations within genes acting as fatty acids sensors. To do so, the metabolic risk factor response to an n-e PUFA supplementation will be compared in carriers and non-carriers of polymorphism within genes acting as fatty acids sensors.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
200
Inclusion Criteria
  • healthy men and women aged between 18 to 50 years;
  • having a BMI between 25 and 40kg/m2;
  • plasma triglycerides levels <4.0 mmol/L;
  • non-smokers;
  • free of any thyroid or metabolic disorders requiring treatment such as diabetes, hypertension, severe dyslipidemia, and coronary heart disease.
Exclusion Criteria
  • subjects taking medication for hyperlipidemia, hypertension, diabetes or taking anticoagulant or n-3 PUFA supplementation;
  • having a taste aversion for fish, fish allergy or regular alcohol drinker;
  • body mass index > 40kg/m2;
  • pregnant or nursing women.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
capsules omega-3n-3 PUFA supplementationOmega-3 supplementation (3g EPA+DHA/d)
Primary Outcome Measures
NameTimeMethod
Change in blood lipids (Total cholesterol, HDL-Cholesterol, Triglycerides)Before and after a 6-weeks supplementation
Secondary Outcome Measures
NameTimeMethod
Change in anthropometric measures (waist and hip girth)Before and after a 6-weeks supplementation
Change in blood pressureBefore and after a 6-weeks supplementation
Change in plasma glycemia and insulin levelsBefore and after a 6-weeks supplementation
Change in gene expression levelsBefore and after a 6-weeks supplementation

Trial Locations

Locations (1)

Institute of Nutraceutical and Functional Foods (INAF), Laval University

🇨🇦

Quebec, Canada

© Copyright 2025. All Rights Reserved by MedPath